Showing results (1841-1850 of 3,434) with videos related to
Sort By:
Pageof 344
Il Giornale Di Chirurgia|September 5, 2019
Mirizzi syndrome: a challenging diagnosis. Case reportR Hassan, L Solinas, M Notarangelo, et al.La Radiologia Medica|August 2, 2001
[Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle]M Bazzocchi, I Berra, G E Francescutti, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|August 10, 2001
A type-II beta-turn, proline-containing, cyclic pentapeptide as a building block for the construction of models of the cleavage site of pro-oxytocinM Dettin, L Falcigno, T Campanile, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2003
Vanadate regulates the insulin mitogenic effect by modulating SHP-2 association with insulin receptor substrate 1 in JAr human choriocarcinoma cellsG Bifulco, M Caruso, C Di Carlo, et al.The Journal of Biological Chemistry|April 14, 1995
Measurements of CO geminate recombination in cytochromes P450 and P420W D Tian, A V Wells, P M Champion, et al.Biochemistry|December 6, 1994
Electrostatic control of the substrate access channel in cytochrome P-450camE Deprez, N C Gerber, C Di Primo, et al.Human Gene Therapy|October 19, 2006
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapyC Di Domenico, D Di Napoli, E Gonzalez Y Reyero, et al.Minerva Pediatrica|May 24, 2007
[Pediatric craniopharyngioma: long-term results in 61 cases]G Pancucci, L Massimi, M Caldarelli, et al.Journal of Endocrinological Investigation|October 28, 2004
Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese menF Giugliano, K Esposito, C Di Palo, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 7, 2013
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?A Scillitani, G Mazziotti, C Di Somma, et al.Pageof 344